Women’s HealthX Unveils Northwell Health, Corewell Health, Biogen & more to headline the Chronic Disease Stage Spotlighting Sex-Specific Data Gaps in Research, Diagnosis, and Care

Women’s HealthX, the number one event redefining the future of women’s healthcare through data, science, and evidence, has announced its unparalleled lineup of healthcare trailblazers speaking on Chronic Disease Management, alongside other specializations including Fertility, Sexual Health, Maternity, Menopause, and Cognitive Health, taking a holistic approach to women’s health. It will bring together 750+ leaders across pharma, health systems, and innovation to address one of the most urgent and underexamined challenges in healthcare: the sex difference gap in data and evidence.

Since cardiovascular disease remains the leading cause of death among women globally, and autoimmune and neurological conditions affect women at significantly higher rates, Women’s HealthX will home in on chronic disease management with 17+ sessions spotlighting case studies and lessons learned. 

The Chronic Disease Management Stage at Women’s HealthX responds directly to this gap, convening senior decision makers and innovators to explore how sex specific science, digital health, and new care models can reshape outcomes for women.

Attending pharma and healthcare organizations include:

  • Tracy Sims, Executive Director, Cardiometabolic Health, Eli Lilly 

  • Adrian Kielhorn, Senior Director, Global Head HEOR Neurology, Alexion Pharmaceuticals 

  • Lauren Powell, Head of Health Equity and Clinical Innovation, Biogen 

  • Amy Kao, SVP, Head of Neuroscience and Immunology Research, EMD Serono 

  • Stella Vnook, Executive Chair and CEO, Kaida Biopharma 

  • Amanda Borsky, Director, Clinical Research, Northwell Health 

  • Lacey McIntosh, Division Chief, Oncologic and Molecular Imaging, UMass Memorial Medical Center 

  • Nicole Turck, Vice President Operations, Women’s Health, Corewell Health 

  • Mette Dyhrberg, CEO, Autoimmune Registry 

  • Lyn Agostinelli, Principal Consultant, Halloran Consulting Group 


Sessions addressing the real gaps in women’s chronic care

The agenda features a series of high-impact sessions tackling the structural and scientific gaps in women’s health:

  • Improving outcomes in obesity through evidence-based person-centered care: Eli Lilly

  • Tackling sex based health inequities by breaking down barriers and bias: Alexion Pharmaceuticals

  • Close the health equity gap in women's health by improving how autoimmune diseases are diagnosed, treated and managed: Autoimmune Registry

  • How a GYN-only care model is driving faster access to gynecological care: Corewell Health

  • Transforming early detection in ovarian cancer: new pathways to accuracy, safety, and better outcomes: UMass Memorial Medical Center

Panel discussions include:

  • Why chronic disease looks different in women and why health systems haven't adapted: Biogen, Kaida Biopharma, EMD Serono

  • How can we better engage with our customers: Northwell Health, Halloran Consulting Group

Register here

Why This Matters Now

Women’s HealthX positions chronic disease not just as a clinical challenge, but as a critical frontier for innovation, investment, and system redesign. From AI-powered monitoring and digital therapeutics to real-world data and integrated care pathways, the stage highlights where meaningful progress is already being made and where the biggest opportunities lie.

For the FemTech ecosystem, this represents a pivotal moment: aligning technology, clinical insight, and commercial strategy to finally close the long-standing data and care gaps in women’s health.


About Women’s HealthX
Women’s HealthX is where the transformation of women’s health begins at its true foundation: data, science, and evidence.

It’s the leading event dedicated to closing the sex difference data gap and accelerating breakthroughs through science-driven, real-world case studies.

Taking place on December 3 to 4, 2026, in Boston, USA, the exhibition will bring together more than 750 healthcare leaders, including clinicians, payers, employers, investors, and policymakers. 7 different stages with 150+ expert speakers taking a holistic approach to women’s health. From fertility, maternity, sexual health, cognitive health, menopause and chronic disease, we address care at every stage of a woman’s life.

Marija ButkovicComment